{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:08:21Z","timestamp":1793156901754,"version":"4.5.0"},"reference-count":75,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.beem.2018.05.004","type":"journal-article","created":{"date-parts":[[2018,5,26]],"date-time":"2018-05-26T05:59:32Z","timestamp":1527314372000},"page":"609-619","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":146,"title":["Familial hypocalciuric hypercalcemia and related disorders"],"prefix":"10.1016","volume":"32","author":[{"given":"Janet Y.","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dolores M.","family":"Shoback","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.beem.2018.05.004_bib1","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1001\/jamasurg.2016.2310","article-title":"The American association of endocrine surgeons guidelines for definitive management of primary hyperparathyroidism","volume":"151","author":"Wilhelm","year":"2016","journal-title":"JAMA Surg"},{"key":"10.1016\/j.beem.2018.05.004_bib2","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1056\/NEJM198001243020402","article-title":"Primary hyperparathyroidism. Incidence, morbidity, and potential economic impact in a community","volume":"302","author":"Heath","year":"1980","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.beem.2018.05.004_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bone.2014.12.003","article-title":"Secular trends in the incidence of primary hyperparathyroidism over five decades (1965-2010)","volume":"73","author":"Griebeler","year":"2015","journal-title":"Bone"},{"key":"10.1016\/j.beem.2018.05.004_bib4","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nrendo.2017.104","article-title":"Primary hyperparathyroidism","volume":"14","author":"Walker","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.beem.2018.05.004_bib5","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/S0022-3476(72)80232-4","article-title":"Familial benign hypercalcemia","volume":"81","author":"Foley","year":"1972","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.beem.2018.05.004_bib6","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/bs.ircmb.2016.05.004","article-title":"The calcium-sensing receptor in health and disease","volume":"327","author":"Diaz-Soto","year":"2016","journal-title":"Int Rev Cell Mol Biol"},{"key":"10.1016\/j.beem.2018.05.004_bib7","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1056\/NEJMoa1300253","article-title":"Mutations affecting G-protein subunit alpha11 in hypercalcemia and hypocalcemia","volume":"368","author":"Nesbit","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.beem.2018.05.004_bib8","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/ng.2492","article-title":"Mutations in AP2S1 cause familial hypocalciuric hypercalcemia type 3","volume":"45","author":"Nesbit","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.beem.2018.05.004_bib9","doi-asserted-by":"crossref","first-page":"R127","DOI":"10.1530\/JME-16-0124","article-title":"Disorders of the calcium-sensing receptor and partner proteins: insights into the molecular basis of calcium homeostasis","volume":"57","author":"Hannan","year":"2016","journal-title":"J\u00a0Mol Endocrinol"},{"key":"10.1016\/j.beem.2018.05.004_bib10","doi-asserted-by":"crossref","first-page":"5079","DOI":"10.1093\/hmg\/ddv226","article-title":"Adaptor protein-2 sigma subunit mutations causing familial hypocalciuric hypercalcaemia type 3 (FHH3) demonstrate genotype-phenotype correlations, codon bias and dominant-negative effects","volume":"24","author":"Hannan","year":"2015","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.beem.2018.05.004_bib11","doi-asserted-by":"crossref","first-page":"E1311","DOI":"10.1210\/jc.2014-1120","article-title":"Codon Arg15 mutations of the AP2S1 gene: common occurrence in familial hypocalciuric hypercalcemia cases negative for calcium-sensing receptor (CASR) mutations","volume":"99","author":"Hendy","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.05.004_bib12","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1210\/jc.2002-020249","article-title":"A\u00a0syndrome of hypocalciuric hypercalcemia caused by autoantibodies directed at the calcium-sensing receptor","volume":"88","author":"Kifor","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.05.004_bib13","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1210\/jc.2010-1739","article-title":"Autoimmune hypocalciuric hypercalcemia unresponsive to glucocorticoid therapy in a patient with blocking autoantibodies against the calcium-sensing receptor","volume":"96","author":"Pallais","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.05.004_bib14","doi-asserted-by":"crossref","first-page":"5443","DOI":"10.1073\/pnas.0701290104","article-title":"An acquired hypocalciuric hypercalcemia autoantibody induces allosteric transition among active human Ca-sensing receptor conformations","volume":"104","author":"Makita","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.beem.2018.05.004_bib15","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/00005792-198111000-00002","article-title":"The hypocalciuric or benign variant of familial hypercalcemia: clinical and biochemical features in fifteen kindreds","volume":"60","author":"Marx","year":"1981","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.beem.2018.05.004_bib16","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1023\/A:1026566418011","article-title":"Familial hypocalciuric hypercalcemia","volume":"1","author":"Heath","year":"2000","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.beem.2018.05.004_bib17","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1172\/JCI117062","article-title":"Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Effects of mutant gene dosage on phenotype","volume":"93","author":"Pollak","year":"1994","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.beem.2018.05.004_bib18","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1056\/NEJM198202043060502","article-title":"An association between neonatal severe primary hyperparathyroidism and familial hypocalciuric hypercalcemia in three kindreds","volume":"306","author":"Marx","year":"1982","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.beem.2018.05.004_bib19","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1172\/JCI119137","volume":"99","author":"Bai","year":"1997","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.beem.2018.05.004_bib20","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1172\/JCI118335","article-title":"Calcium-sensing receptor mutations in familial benign hypercalcemia and neonatal hyperparathyroidism","volume":"96","author":"Pearce","year":"1995","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.beem.2018.05.004_bib21","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ceca.2003.10.010","article-title":"Diseases associated with the extracellular calcium-sensing receptor","volume":"35","author":"Thakker","year":"2004","journal-title":"Cell Calcium"},{"key":"10.1016\/j.beem.2018.05.004_bib22","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1056\/NEJM199610103351505","article-title":"A\u00a0familial syndrome of hypocalcemia with hypercalciuria due to mutations in the calcium-sensing receptor","volume":"335","author":"Pearce","year":"1996","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.beem.2018.05.004_bib23","doi-asserted-by":"crossref","first-page":"458","DOI":"10.3389\/fphys.2016.00458","article-title":"Autosomal dominant hypocalcemia (hypoparathyroidism) types 1 and 2","volume":"7","author":"Roszko","year":"2016","journal-title":"Front Physiol"},{"key":"10.1016\/j.beem.2018.05.004_bib24","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/366575a0","article-title":"Cloning and characterization of an extracellular Ca(2+)-sensing receptor from bovine parathyroid","volume":"366","author":"Brown","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.beem.2018.05.004_bib25","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/ng0792-295","article-title":"The gene responsible for familial hypocalciuric hypercalcemia maps to chromosome 3q in four unrelated families","volume":"1","author":"Chou","year":"1992","journal-title":"Nat Genet"},{"key":"10.1016\/j.beem.2018.05.004_bib26","doi-asserted-by":"crossref","first-page":"12919","DOI":"10.1074\/jbc.270.21.12919","article-title":"Molecular cloning and functional expression of human parathyroid calcium receptor cDNAs","volume":"270","author":"Garrett","year":"1995","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.beem.2018.05.004_bib27","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/MED.0b013e32834c3c7c","article-title":"Familial hypocalciuric hypercalcaemia: a review","volume":"18","author":"Christensen","year":"2011","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.beem.2018.05.004_bib28","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1210\/jcem-62-2-445","article-title":"Secretory dysfunction in parathyroid cells from a neonate with severe primary hyperparathyroidism","volume":"62","author":"Marx","year":"1986","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.05.004_bib29","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1210\/jcem-67-5-944","article-title":"Relationship between the concentration and rate of change of calcium and serum intact parathyroid hormone levels in normal humans","volume":"67","author":"Brent","year":"1988","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.05.004_bib30","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/nrm1154","article-title":"Extracellular calcium sensing and signalling","volume":"4","author":"Hofer","year":"2003","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.beem.2018.05.004_bib31","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.beem.2013.05.010","article-title":"Calcium-sensing receptor (CaSR): pharmacological properties and signaling pathways","volume":"27","author":"Conigrave","year":"2013","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.05.004_bib32","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1681\/ASN.2012030323","article-title":"Deficiency of the calcium-sensing receptor in the kidney causes parathyroid hormone-independent hypocalciuria","volume":"23","author":"Toka","year":"2012","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.beem.2018.05.004_bib33","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1172\/JCI111016","article-title":"Urinary calcium excretion in familial hypocalciuric hypercalcemia. Persistence of relative hypocalciuria after induction of hypoparathyroidism","volume":"72","author":"Attie","year":"1983","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.beem.2018.05.004_bib34","doi-asserted-by":"crossref","first-page":"F485","DOI":"10.1152\/ajprenal.00608.2009","article-title":"Physiology and pathophysiology of the calcium-sensing receptor in the kidney","volume":"298","author":"Riccardi","year":"2010","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.beem.2018.05.004_bib35","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/nrneph.2016.59","article-title":"Localization and function of the renal calcium-sensing receptor","volume":"12","author":"Riccardi","year":"2016","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.beem.2018.05.004_bib36","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1172\/JCI119299","article-title":"Apical extracellular calcium\/polyvalent cation-sensing receptor regulates vasopressin-elicited water permeability in rat kidney inner medullary collecting duct","volume":"99","author":"Sands","year":"1997","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.beem.2018.05.004_bib37","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1359\/jbmr.1997.12.12.1959","article-title":"Expression of an extracellular calcium-sensing receptor in human and mouse bone marrow cells","volume":"12","author":"House","year":"1997","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2018.05.004_bib38","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1006\/bbrc.1998.8178","article-title":"Expression of extracellular calcium (Ca2 + o)-sensing receptor in the clonal osteoblast-like cell lines, UMR-106 and SAOS-2","volume":"243","author":"Yamaguchi","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.beem.2018.05.004_bib39","doi-asserted-by":"crossref","first-page":"5883","DOI":"10.1210\/endo.140.12.7190","article-title":"Expression and signal transduction of calcium-sensing receptors in cartilage and bone","volume":"140","author":"Chang","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.beem.2018.05.004_bib40","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.1210\/en.2007-0147","article-title":"Constitutive activity of the osteoblast Ca2+-sensing receptor promotes loss of cancellous bone","volume":"148","author":"Dvorak","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.beem.2018.05.004_bib41","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1006\/bbrc.1999.0932","article-title":"High extracellular calcium inhibits osteoclast-like cell formation by directly acting on the calcium-sensing receptor existing in osteoclast precursor cells","volume":"261","author":"Kanatani","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.beem.2018.05.004_bib42","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1006\/bbrc.1998.8448","article-title":"Calcium-sensing receptor in mature osteoclasts, which are bone resorbing cells","volume":"245","author":"Kameda","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.beem.2018.05.004_bib43","doi-asserted-by":"crossref","first-page":"ra1","DOI":"10.1126\/scisignal.1159945","article-title":"The extracellular calcium-sensing receptor (CaSR) is a critical modulator of skeletal development","volume":"1","author":"Chang","year":"2008","journal-title":"Sci Signal"},{"key":"10.1016\/j.beem.2018.05.004_bib44","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/j.1365-2265.2009.03557.x","article-title":"Skeletal consequences of familial hypocalciuric hypercalcaemia vs. primary hyperparathyroidism","volume":"71","author":"Christensen","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.beem.2018.05.004_bib45","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s002230001201","article-title":"The prevalence of familial hypocalciuric hypercalcemia","volume":"68","author":"Hinnie","year":"2001","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.beem.2018.05.004_bib46","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/jbmr.3339","article-title":"Familial hypocalciuric hypercalcemia as an atypical form of primary hyperparathyroidism","volume":"33","author":"Marx","year":"2018","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2018.05.004_bib47","doi-asserted-by":"crossref","first-page":"351","DOI":"10.7326\/0003-4819-92-3-351","article-title":"Familial hypocalciuric hypercalcemia: recognition among patients referred after unsuccessful parathyroid exploration","volume":"92","author":"Marx","year":"1980","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.beem.2018.05.004_bib48","doi-asserted-by":"crossref","first-page":"511","DOI":"10.7326\/0003-4819-102-4-511","article-title":"Familial benign hypercalcemia (hypocalciuric hypercalcemia). Clinical and pathogenetic studies in 21 families","volume":"102","author":"Law","year":"1985","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.beem.2018.05.004_bib49","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1136\/bmj.282.6269.1023","article-title":"Familial hypocalciuric hypercalcaemia and acute pancreatitis","volume":"282","author":"Davies","year":"1981","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.beem.2018.05.004_bib50","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.jbspin.2009.02.001","article-title":"Familial hypocalciuric hypercalcemia revealed by chondrocalcinosis","volume":"76","author":"Volpe","year":"2009","journal-title":"Jt Bone Spine"},{"key":"10.1016\/j.beem.2018.05.004_bib51","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1056\/NEJM198010023031409","article-title":"Familial hypocalciuric hypercalcemia","volume":"303","author":"Marx","year":"1980","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.beem.2018.05.004_bib52","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1111\/j.1445-5994.1990.tb00407.x","article-title":"Familial hypocalciuric hypercalcaemia and pancreatitis: no causal link proven","volume":"20","author":"Stuckey","year":"1990","journal-title":"Aust N Z J Med"},{"key":"10.1016\/j.beem.2018.05.004_bib53","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0002-9343(92)90229-5","article-title":"Significant developmental elevation in serum parathyroid hormone levels in a large kindred with familial benign (hypocalciuric) hypercalcemia","volume":"93","author":"McMurtry","year":"1992","journal-title":"Am J Med"},{"key":"10.1016\/j.beem.2018.05.004_bib54","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2014-206473","article-title":"Parathyroid adenoma in a patient with familial hypocalciuric hypercalcaemia","volume":"2014","author":"Forde","year":"2014","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.beem.2018.05.004_bib55","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0046-8177(81)80123-2","article-title":"The parathyroid glands in familial hypocalciuric hypercalcemia","volume":"12","author":"Thorgeirsson","year":"1981","journal-title":"Hum Pathol"},{"key":"10.1016\/j.beem.2018.05.004_bib56","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/j.1365-2265.2008.03259.x","article-title":"Discriminative power of three indices of renal calcium excretion for the distinction between familial hypocalciuric hypercalcaemia and primary hyperparathyroidism: a follow-up study on methods","volume":"69","author":"Christensen","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.beem.2018.05.004_bib57","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/0002-9343(84)90852-0","article-title":"Parathyroid glands in familial benign hypercalcemia (familial hypocalciuric hypercalcemia)","volume":"76","author":"Law","year":"1984","journal-title":"Am J Med"},{"key":"10.1016\/j.beem.2018.05.004_bib58","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s12672-011-0100-8","article-title":"Frequent germ-line mutations of the MEN1, CASR, and HRPT2\/CDC73 genes in young patients with clinically non-familial primary hyperparathyroidism","volume":"3","author":"Starker","year":"2012","journal-title":"Horm Cancer"},{"key":"10.1016\/j.beem.2018.05.004_bib59","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1210\/jc.2017-01606","article-title":"Calcimimetic use in familial hypocalciuric hypercalcemia-a perspective in endocrinology","volume":"102","author":"Marx","year":"2017","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.05.004_bib60","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMc1511646","article-title":"Cinacalcet for symptomatic hypercalcemia caused by AP2S1 mutations","volume":"374","author":"Howles","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.beem.2018.05.004_bib61","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.bcp.2010.04.002","article-title":"Clinical utility of calcimimetics targeting the extracellular calcium-sensing receptor (CaSR)","volume":"80","author":"Brown","year":"2010","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.beem.2018.05.004_bib62","doi-asserted-by":"crossref","first-page":"R189","DOI":"10.1530\/EJE-15-1028","article-title":"Genetics in endocrinology: gain and loss of function mutations of the calcium-sensing receptor and associated proteins: current treatment concepts","volume":"174","author":"Mayr","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2018.05.004_bib63","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/jbmr.3241","article-title":"Cinacalcet rectifies hypercalcemia in a patient with familial hypocalciuric hypercalcemia type 2 (FHH2) caused by a germline loss-of-function Galpha11 mutation","volume":"33","author":"Gorvin","year":"2018","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2018.05.004_bib64","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1210\/jc.2015-1518","article-title":"Cinacalcet treatment in an adolescent with concurrent 22q11.2 deletion syndrome and familial hypocalciuric hypercalcemia type 3 caused by AP2S1 mutation","volume":"100","author":"Tenhola","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.05.004_bib65","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.semcdb.2015.12.004","article-title":"Interplay between CaSR and PTH1R signaling in skeletal development and osteoanabolism","volume":"49","author":"Santa Maria","year":"2016","journal-title":"Semin Cell Dev Biol"},{"key":"10.1016\/j.beem.2018.05.004_bib66","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1210\/jc.2004-0842","article-title":"Cinacalcet hydrochloride maintains long-term normocalcemia in patients with primary hyperparathyroidism","volume":"90","author":"Peacock","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.05.004_bib67","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1210\/jc.2008-2640","article-title":"Cinacalcet reduces serum calcium concentrations in patients with intractable primary hyperparathyroidism","volume":"94","author":"Marcocci","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.05.004_bib68","doi-asserted-by":"crossref","first-page":"4860","DOI":"10.1210\/jc.2009-1472","article-title":"Cinacalcet treatment of primary hyperparathyroidism: biochemical and bone densitometric outcomes in a five-year study","volume":"94","author":"Peacock","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.05.004_bib69","doi-asserted-by":"crossref","first-page":"E9","DOI":"10.1210\/jc.2010-1221","article-title":"Cinacalcet HCl reduces hypercalcemia in primary hyperparathyroidism across a wide spectrum of disease severity","volume":"96","author":"Peacock","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.05.004_bib70","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1530\/EJE-14-0877","article-title":"Cinacalcet normalizes serum calcium in a double-blind randomized, placebo-controlled study in patients with primary hyperparathyroidism with contraindications to surgery","volume":"172","author":"Khan","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2018.05.004_bib71","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1001\/jama.2016.19468","article-title":"Effect of etelcalcetide vs cinacalcet on serum parathyroid hormone in patients receiving hemodialysis with secondary hyperparathyroidism: a randomized clinical trial","volume":"317","author":"Block","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.beem.2018.05.004_bib72","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1001\/jama.2016.19456","article-title":"Effect of etelcalcetide vs placebo on serum parathyroid hormone in patients receiving hemodialysis with secondary hyperparathyroidism: two randomized clinical trials","volume":"317","author":"Block","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.beem.2018.05.004_bib73","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1056\/NEJMoa1205624","article-title":"Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis","volume":"367","author":"Investigators","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.beem.2018.05.004_bib74","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.1210\/jc.2007-0585","article-title":"Cinacalcet hydrochloride reduces the serum calcium concentration in inoperable parathyroid carcinoma","volume":"92","author":"Silverberg","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.05.004_bib75","article-title":"Successful treatment of neonatal severe hyperparathyroidism with cinacalcet in two patients","volume":"2015","author":"Fisher","year":"2015","journal-title":"Endocrinol Diabetes Metab Case Rep"}],"container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X18300721?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X18300721?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:53:47Z","timestamp":1761497627000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X18300721"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":75,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S1521690X18300721"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2018.05.004","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Familial hypocalciuric hypercalcemia and related disorders","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2018.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}